AIM: As the primary relevant tissue (brain) for psychiatric disorders is commonly not available, we aimed to investigate whether blood can be used as a proxy in methylation studies on the basis of two models. In the 'signature' model methylation-disease associations occur because a disease-causing factor affected methylation in the blood. In the 'mirror-site' model the methylation status in the blood is correlated with the corresponding disease-causing site in the brain. MATERIALS, METHODS & RESULTS: Methyl-binding domain enrichment and next-generation sequencing of the blood, cortex and hippocampus from four haloperidol-treated and ten untreated C57BL/6 mice revealed high levels of correlation in methylation across tissues. Despite the treatment inducing a large number of methylation changes, this correlation remains high. CONCLUSION: Our results show that, consistent with the signature model, factors that affect brain processes (i.e., haloperidol) leave biomarker signatures in the blood and, consistent with the mirror-site model, the methylation status of many sites in the blood mirror those in the brain.
AIM: As the primary relevant tissue (brain) for psychiatric disorders is commonly not available, we aimed to investigate whether blood can be used as a proxy in methylation studies on the basis of two models. In the 'signature' model methylation-disease associations occur because a disease-causing factor affected methylation in the blood. In the 'mirror-site' model the methylation status in the blood is correlated with the corresponding disease-causing site in the brain. MATERIALS, METHODS & RESULTS: Methyl-binding domain enrichment and next-generation sequencing of the blood, cortex and hippocampus from four haloperidol-treated and ten untreated C57BL/6 mice revealed high levels of correlation in methylation across tissues. Despite the treatment inducing a large number of methylation changes, this correlation remains high. CONCLUSION: Our results show that, consistent with the signature model, factors that affect brain processes (i.e., haloperidol) leave biomarker signatures in the blood and, consistent with the mirror-site model, the methylation status of many sites in the blood mirror those in the brain.
Authors: Kevin Judd McKernan; Heather E Peckham; Gina L Costa; Stephen F McLaughlin; Yutao Fu; Eric F Tsung; Christopher R Clouser; Cisyla Duncan; Jeffrey K Ichikawa; Clarence C Lee; Zheng Zhang; Swati S Ranade; Eileen T Dimalanta; Fiona C Hyland; Tanya D Sokolsky; Lei Zhang; Andrew Sheridan; Haoning Fu; Cynthia L Hendrickson; Bin Li; Lev Kotler; Jeremy R Stuart; Joel A Malek; Jonathan M Manning; Alena A Antipova; Damon S Perez; Michael P Moore; Kathleen C Hayashibara; Michael R Lyons; Robert E Beaudoin; Brittany E Coleman; Michael W Laptewicz; Adam E Sannicandro; Michael D Rhodes; Rajesh K Gottimukkala; Shan Yang; Vineet Bafna; Ali Bashir; Andrew MacBride; Can Alkan; Jeffrey M Kidd; Evan E Eichler; Martin G Reese; Francisco M De La Vega; Alan P Blanchard Journal: Genome Res Date: 2009-06-22 Impact factor: 9.043
Authors: Thomas A Down; Vardhman K Rakyan; Daniel J Turner; Paul Flicek; Heng Li; Eugene Kulesha; Stefan Gräf; Nathan Johnson; Javier Herrero; Eleni M Tomazou; Natalie P Thorne; Liselotte Bäckdahl; Marlis Herberth; Kevin L Howe; David K Jackson; Marcos M Miretti; John C Marioni; Ewan Birney; Tim J P Hubbard; Richard Durbin; Simon Tavaré; Stephan Beck Journal: Nat Biotechnol Date: 2008-07 Impact factor: 54.908
Authors: Brock C Christensen; E Andres Houseman; Carmen J Marsit; Shichun Zheng; Margaret R Wrensch; Joseph L Wiemels; Heather H Nelson; Margaret R Karagas; James F Padbury; Raphael Bueno; David J Sugarbaker; Ru-Fang Yeh; John K Wiencke; Karl T Kelsey Journal: PLoS Genet Date: 2009-08-14 Impact factor: 5.917
Authors: Karolina A Aberg; Joseph L McClay; Srilaxmi Nerella; Shaunna Clark; Gaurav Kumar; Wenan Chen; Amit N Khachane; Linying Xie; Alexandra Hudson; Guimin Gao; Aki Harada; Christina M Hultman; Patrick F Sullivan; Patrik K E Magnusson; Edwin J C G van den Oord Journal: JAMA Psychiatry Date: 2014-03 Impact factor: 21.596
Authors: Erin R Ewald; Gary S Wand; Fayaz Seifuddin; Xiaoju Yang; Kellie L Tamashiro; James B Potash; Peter Zandi; Richard S Lee Journal: Psychoneuroendocrinology Date: 2014-03-20 Impact factor: 4.905
Authors: Shaunna L Clark; Karolina A Aberg; Srilaxmi Nerella; Gaurav Kumar; Joseph L McClay; Wenan Chen; Linying Y Xie; Aki Harada; Andrey A Shabalin; Guimin Gao; Sarah E Bergen; Christina M Hultman; Patrik K E Magnusson; Patrick F Sullivan; Edwin J C G van den Oord Journal: Alcohol Clin Exp Res Date: 2015-07-04 Impact factor: 3.455
Authors: Shaunna L Clark; Blair N Costin; Robin F Chan; Alexander W Johnson; Linying Xie; Jessica L Jurmain; Gaurav Kumar; Andrey A Shabalin; Ashutosh K Pandey; Karolina A Aberg; Michael F Miles; Edwin van den Oord Journal: Alcohol Clin Exp Res Date: 2018-11-11 Impact factor: 3.455
Authors: Corinde E Wiers; Falk W Lohoff; Jisoo Lee; Christine Muench; Clara Freeman; Amna Zehra; Stefano Marenco; Barbara K Lipska; Pavan K Auluck; Ningping Feng; Hui Sun; David Goldman; James M Swanson; Gene-Jack Wang; Nora D Volkow Journal: Eur J Neurosci Date: 2018-08 Impact factor: 3.386
Authors: Beth Wilmot; Rebecca Fry; Lisa Smeester; Erica D Musser; Jonathan Mill; Joel T Nigg Journal: J Child Psychol Psychiatry Date: 2015-08-25 Impact factor: 8.982
Authors: Gaurav Kumar; Shaunna L Clark; Joseph L McClay; Andrey A Shabalin; Daniel E Adkins; Linying Xie; Robin Chan; Srilaxmi Nerella; Yunjung Kim; Patrick F Sullivan; Christina M Hultman; Patrik K E Magnusson; Karolina A Aberg; Edwin J C G van den Oord Journal: Hum Genet Date: 2014-10-07 Impact factor: 4.132